34 research outputs found
Akromegalija, nedostatak i suviŔak hormona rasta (Acromegaly, Growth Hormone Deficiency and Excess)
Dehydroepiandrosterone Sulfate and Arterial Hypertension
Dehydroepiandrosterone sulfate (DHEAS) is a steroid molecule whose function and mechanism of action in the human body are still inadequately researched. A potential protective function for the cardiovascular system can be explained by activation of nitric oxide production, impact on endothelial and mitochondrial function, and inhibition of proinflammatory cytokine production (IL-6 and TNF-Ī±). Some research shows the beneficial effects of DHEA/DHEAS on many bodily functions, especially in the cardiovascular and the neurological systems. However, we need to be careful with interpretation of the results because of different criteria used for defining arterial hypertension, the race that was observed, and reproductive status of women, as these factors can change the conclusion. Due to a lack of evidence, DHEAS supplementation is still not recommended. We need multicentric prospective and randomized studies on DHEAS to examine its potential impact on blood pressure regulation and cardiovascular risk
A Body Shape Index versus Systematic Coronary Risk Evaluation2 algorithm and Atherosclerotic Cardiovascular Disease Risk Score ā is there a connection?
Medical students\u27 attitudes towards terminology of obesity
Introduction:
Obesity, one of the most common health problems encountered in medicine with implications in various other health issues, is nowadays omnipresent. Terminology describing diagnosis of obesity might be considered rude or offensive. Since perception of obese people is sometimes associated with negative attitudes and stereotypes, proper terminology used by physicians is crucial
Exercise heart rate recovery in obesity
Introduction: Obesity is an epidemic that carries significant cardiovascular (CV) burden. Autonomic
dysfunction, characterized by reduced vagal tone and sympathetic overactivity, has been found in diabetes,
hypertension, heart failure, metabolic syndrome, and other conditions. Heart rate decrease after
exercise, or heart rate recovery (HRR) reflects cardiac autonomic activity. Decreased HRR is a powerful
predictor of CV disease, CV and all-cause mortality.1-3
Patients and Methods: A total of 54 obese patients (24% male, 76% female), age 22-66 (mean 47 year),
BMI 29.4-53.3 (mean 40.3 kg/m2), were enrolled in a multidisciplinary weight management program.
Treadmill testing was done initially and after 6-month follow-up. Standard Bruce protocol was used to
assess exercise capacity and passive HRR (15 sec, 3 and 6 min into the recovery period, as per institutional
protocol). Control group was composed of age- and sex-matched non-obese subjects.
Results: Obese subjects had significantly slower HRR (HRR0:15 6.1 vs. 9.1 BPM, HRR3:00 57.8 vs. 66.6
BPM, HRR6:00 63.3 vs. 72.7 BPM; p=0.0216, 0.0006, 0.0004, respectively). Exercise capacity was also significantly
lower in comparison to control (6.7 vs. 8.6 METs; p=0.000001), with reduced exercise time (6.0
vs. 8.2 min; p=0.000001). Sixteen subjects that reached 6-month follow-up lost 5.4 kg on average. Exercise
capacity increased mildly (6.4 to 7.1 METs; NS), as well as total exercise time (5.6 to 6.6 min; NS).
Discussion and Conclusion: Physiological HRR kinetics follows exponential decay function. Rapid first
phase, mediated by vagal reactivation is followed by a gradual HRR decline, dominated by sympathetic
withdrawal. We found significantly slower HRR over different time-points in the obese, which
reflects autonomic imbalance. Functional aerobic capacity was also significantly reduced. Somewhat
improved functional capacity and dynamics of HRR after weight loss did not reach statistical power. To
conclude, we found evidence of significantly impaired cardiac autonomic function in obese subjects,
together with reduced functional capacity. As the study is ongoing, we hope to demonstrate sustained
effect of exercise and diet on autonomic function. Potential benefit on mortality and CV risk reduction
should encourage patients and health care providers to manage obesity more vigorously
Estradiol impact on hypertension profile in obese patients
Introduction: Obesity is a well-known risk factor for developing hypertension. Prehypertensive patients
(with an average 24h monitored blood pressure between 120/85 and 139/89mmHg) rarely get
physicianās attention despite their differences from non-hypertensive patients.1,2
Patients and Methods: We enrolled 42 obese female patients (age range from 26 to 69 years) from a
multidisciplinary weight management program (BMI range 30 to 49.9 kg/m2). Firstly, because of estradiol
levels, patients were divided into two groups, younger than 50 years (A) and older (B). Due to the
average values of patientās ambulatory monitored blood pressure, patients were additionally put into
three groups (1 = below 120/85mmHg, 2 = between 120/85 to 139/89mmHg 3 = above 140/90mmHg). Systolic
dipping profile, estradiol levels, and average nocturnal heart rate were also checked.
Results: Prehypertensive obese patients older than 50 years (B)
had higher nocturnal heart rate (58.50 vs. 70.25/min; p<0.05).
Even though differences were found in younger patients, they
were not statistically significant. Systolic dipping profile was
different and age-dependent (Non-dippers A: 44.00%; B 82.35%;
p=0.02). The number of non-dippers in the younger group was
highest in group 2 (66% vs. 20% in group 1; p=0.03) while there
were no differences in the older group. The prehypertensive
group had very similar results to hypertensive patients. Estradiol
levels (Figure 1) were age independently lower in non-dippers (A:
185.5 vs. 201.07, NS; B: 71.9 vs. 87.0, NS) and also in hypertensive
patients (A: 111.0 vs 192.6 pmol/L, p=0.21; B: 59.0 vs. 98.0 pmol/L).
Conclusion: Our results showed that estradiol levels seem to be
protective in terms of blood pressure stability, systolic dipping
profile and nocturnal heart rate probably due to its impact on autonomic
nerve system functionality. Because of a small number
of patients further investigation is needed to prove the statistical
significance of this statement
Maligni limfomi Å”titnjaÄe
Primary thyroid lymphoma is a rare disease that accounts for about 5% of all thyroid neoplasms. It shows a female predominance, especially in women with a pre-existing Hashimoto.s disease. During a 15-year period, 11 patients were diagnosed with primary thyroid lymphoma at Department of Endocrinology, Diabetes and Metabolic Diseases, Sestre milosrdnice University Hospital. There were no records on associated Hashimoto.s thyroiditis in any of them, which is inconsistent with the international literature reporting on such association in 40%-80% of cases. Painless neck edema was the most common physical symptom for patient presentation. The diagnosis was based on fine needle aspiration cytology, while the spread of disease to other organ systems was ruled out by other studies (computed tomography, ultrasonography and gallium scintigraphy). However, it should be noted that diffuse or nodular lymphoma cannot always be classified only by aspiration cytology. The World Health Organization classification was used. Today, it has been generally accepted that thyroid lymphomas belong to a group of lymphomas associated with mucosa-associated lymphoid tissue (MALT). The most common form of nonHodgkin\u27s lymphoma (NHL) of the thyroid was B-cell phenotype lymphoma with a high malignancy grade. All patients were treated with chemotherapy according to the CHOP protocol (cyclophosphamide, doxorubicin, vincristine, prednisone). Eight patients underwent surgical treatment, three of them for compressive syndrome, followed by radiotherapy. The follow-up of patients with primary thyroid lymphoma revealed high disease aggressiveness and short survival, while complete remission was only occasionally recorded.Primarni limfomi Å”titnjaÄe su rijetka bolest, a pojavljuju se u oko 5% sluÄajeva svih neoplazma Å”titnjaÄe. ÄeÅ”Äe se javljaju kod žena, osobito onih s prethodno postojeÄom Hashimotovom boleÅ”Äu. U Zavodu za hematologiju KliniÄke bolnice "Sestre milosrdnice" u 15-godiÅ”njem razdoblju dijagnosticirano je 11 bolesnika s primarnim limfomom Å”titnjaÄe. Ni za jednog bolesnika, meÄutim, nije se znalo da boluje od pridruženog Hashimotovog tiroiditisa, Å”to se ne uklapa u podatke iz svjetske znanstvene literature koji govore o 40%-80%. NajÄeÅ”Äi simptom koji je doveo bolesnika na pregled lijeÄniku bila je bezbolna oteklina vrata. Dijagnoza je postavljena putem aspiracijske citopunkcije, a ostalim pretragama (CT, UZV, scintigrafija tijela radiogalijem) iskljuÄena je proÅ”irenost bolesti u druge organske sustave (staging). Treba, meÄutim, napomenuti kako iskljuÄivo citopunkcijom nije uvijek moguÄe klasificirati difuzni i nodularni limfom. Klasifikacija je provedena prema Svjetskoj zdravstvenoj organizaciji. Danas je opÄenito prihvaÄeno miÅ”ljenje da limfomi Å”titnjaÄe pripadaju skupini limfoma pridruženih mukoznom limfatiÄnom tkivu (MALT, mucosa associated lymphoid tissue). NajÄeÅ”Äi oblik ne-Hodgkinovog limfoma (NHL) Å”titnjaÄe bio je B staniÄni fenotip visokog stupnja malignosti. Svi bolesnici su lijeÄeni kemoterapijom po shemi CHOP (ciklofosfamid, doksorubicin, vinkristin, prednizon), a kod 8 bolesnika je primijenjen kirurÅ”ki zahvat, od toga kod troje zbog kompresivnog sindroma, a potom je provedena radioterapija. PraÄenjem bolesnika s primarnim limfomom Å”titnjaÄe uoÄena je velika agresivnost bolesti i kratko preživljavanje, ali su rjeÄe moguÄe i potpune remisije
Panhipopituitarizam u 45-godiÅ”nje bolesnice: prikaz sluÄaja
A case of a 45-year-old woman with untreated panhypopituitarism is presented. Hypopituitarism is a rare disorder consisting of multiple deficiencies of hormones originating from the adenohypophysis. It is divided into primary and secondary. Primary disorders manifest at the pituitary level, whereas secondary hypopituitarism implies hypothalamic affection. Partial or total loss of all pituitary hormones is called panhypopituitarism. Hypopituitarism can be slow and insidious or severe and life-threatening. The expression of symptoms largely depends on the patient\u27s age and the hormones involved. The leading symptom is growth retardation when the disorder develops in childhood or puberty. Sometimes years may elapse without accurate diagnosis, as in the case described. To date, only a few cases of untreated hypopituitarism have been published. In our patient, clinical examination revealed short stature and weak osteomuscular constitution, primary amenorrhea and lack of development of secondary sex characteristics. The patient\u27s clinical history revealed signs of hypopituitarism from childhood, which had been untreated until she presented to our clinic. The results of complete testing showed the lack of all pituitary hormones and antidiuretic hormone, which was consistent with panhypopituitarism, including central diabetes insipidus.Prikazuje se sluÄaj 45-godiÅ”nje bolesnice s nelijeÄenim panhipopituitarizmom. Hipopituitarizam je rijedak poremeÄaj koji obilježava manjak viÅ”e hormona prednjega režnja hipofize. Može biti primaran ili sekundaran. Primarni poremeÄaji nastaju na razini hipofize, dok su sekundarni na razini hipotalamusa. DjelomiÄan ili potpun manjak svih hormona hipofize naziva se panhipopituitarizam. Tijek hipopituitarizma može biti spor i podmukao ili nagao i životno ugrožavajuÄi. Izražajnost simptoma ovisi prvenstveno o dobi bolesnika te zahvaÄenim hormonima. VodeÄi simptom je zaostajanje u rastu, kada bolest zahvati bolesnika u djetinjstvu ili pubertetu. Ponekad može proÄi niz godina bez potpune dijagnoze, kao Å”to je opisano i u naÅ”e bolesnice. Do danas je objavljeno svega nekoliko sluÄajeva nelijeÄenog hipopituitarizma. KliniÄkim pregledom naÅ”e bolesnice naÄen je nizak rast i slaba osteomuskularna graÄa, primarna amenoreja i nerazvijene sekundarne spolne znaÄajke. AnamnestiÄki podaci otkrivaju sliku hipopituitarizma od djeÄje dobi, ali bolesnica nije lijeÄena do dolaska u naÅ”u kliniku. Rezultati sveobuhvatne obrade pokazali su manjak svih hormona hipofize i antidiuretiÄnog hormona, Å”to govori u prilog panhipopituitarizma, ukljuÄujuÄi i centralni dijabetes insipidus